Jolanta Rzymowska

Prof. Dr. Jolanta Rzymowska

Department of Biology and Genetics, Medical University of Lublin
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
RNRenata Nowak
Renata Nowak
Marta OlechMarta Olech
Marta Olech
Łukasz PecioŁukasz Pecio
Łukasz Pecio
Wieslaw OleszekWieslaw Oleszek
Wieslaw Oleszek
RLRenata Los
Renata Los
JRJolanta Rzymowska
Jolanta Rzymowska

1 March 2016 in LWT
Verified
Journal Article
Closed access
WRWojciech Radzki
Wojciech Radzki
MZMarta Ziaja-Sołtys
Marta Ziaja-Sołtys
JNJakub Nowak
Jakub Nowak
JRJolanta Rzymowska
Jolanta Rzymowska
JTJolanta Topolska
Jolanta Topolska
AKAndrzej Kuczumow
Andrzej Kuczumow

8 August 2014 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
LGLudmiła Grzybowska-Szatkowska
Ludmiła Grzybowska-Szatkowska
BŚBrygida Ślaska
Brygida Ślaska
JRJolanta Rzymowska
Jolanta Rzymowska
ABAnna Brzozowska
Anna Brzozowska
BFBolesław Floriańczyk
Bolesław Floriańczyk
The role of the mitochondria in the process of carcinogenesis, mainly oxidative phosphorylation, mostly concerns their participation in the production of free radicals and ATP and in the process of apoptosis. The purpose of this study was to detect potential changes in the genes encoding the subunits 6 and 8 of the ATP synthase and their impact on the enzyme's biochemical properties, structure and function in patients with breast tumors. The tested material was mitochondrial DNA (mtDNA) isolated from specimens of ductal carcinoma (carcinoma ductale) Tp1-2Np0-1Mp0, blood and non-cancerous tissue of mammary gland (control), sampled from 50 patients who had been operated for breast cancer. In the case of missense-type changes in the mtDNA, protein prediction software was used to assess their effect on the biochemical properties of the protein, its structure and function. We identified 8 changes in the ATP6 gene in 36/50 examined breast cancer cell samples and 5 changes in the ATP8 gene (10/50). Most of them were homoplasmic changes of missense type. Four of the changes (A8439C, G8858C, C9130G and T9119G) had not been described in the literature before. The identified mutations and polymorphisms, especially those of missense type, can affect mitochondrial functions, especially if the conservative domain of the protein is concerned. Replacement of ‘wild-type’ mtDNA by mutated mtDNA can be an important event in carcinogenesis.

1 January 2016 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
RNRenata Nowak
Renata Nowak
KSKatarzyna Dos Santos Szewczyk
Katarzyna Dos Santos Szewczyk
Urszula Gawlik-DzikiUrszula Gawlik-Dziki
Urszula Gawlik-Dziki
JRJolanta Rzymowska
Jolanta Rzymowska
Lukasz KomstaLukasz Komsta
Lukasz Komsta
The cytotoxic and antioxidant properties of lipophilic compounds extracted from different parts of four Chenopodium L. (Chenopodium album, Chenopodium hybridum, Chenopodium rubrum and Chenopodium urbicum) species were evaluated. The highest phenolic content was found in herb and seeds of all examined plants. Large amounts of free polyphenols were observed in herb extracts of C. album (3.36 mg/g DW), seeds of C. urbicum (3.87 mg/g DW) and roots of C. urbicum (1.52 mg/g DW). The cytotoxic activities of the extracts were assessed against human lung carcinoma A-549 and ovarian carcinoma TOV-112D and normal human fibroblast cell lines. Our study demonstrated that the extracts from the herb of C. rubrum and C. urbicum had the best antioxidant effect of all the extracts analyzed. Most of the extracts tested exhibited low cytotoxicity. However, the extracts from herb and seeds of C. album and C. hybridum showed the significant antiproliferative effect on the TOV-112 cell line. It can be concluded that antioxidant activity and phenolic composition differ mainly between plant parts and are quite similar between the plants, when the same plant part is analyzed. Thus, the Chenopodium extracts could be used as a readily accessible source of natural antioxidants, and may be used in the pharmaceutical industry and for food supplements production.

25 February 2019 in APMIS
Verified
Journal Article
Closed access
PDF file
MFMarta Julia Fiołka
Marta Julia Fiołka
JRJolanta Rzymowska
Jolanta Rzymowska
SBSylwia Bilska
Sylwia Bilska
KLKinga Lewtak
Kinga Lewtak
MDMagdalena Dmoszyńska‐Graniczka
Magdalena Dmoszyńska‐Graniczka
TUTeresa Urbanik-Sypniewska
Teresa Urbanik-Sypniewska

Verified
Journal Article
Open access
PDF file
PKPaulina Kozakiewicz
Paulina Kozakiewicz
LGLudmiła Grzybowska-Szatkowska
Ludmiła Grzybowska-Szatkowska
MCMarzanna Ciesielka
Marzanna Ciesielka
JRJolanta Rzymowska
Jolanta Rzymowska
The mitochondria are essential for normal cell functioning. Changes in mitochondrial DNA (mtDNA) may affect the occurrence of some chronic diseases and cancer. This process is complex and not entirely understood. The assignment to a particular mitochondrial haplogroup may be a factor that either contributes to cancer development or reduces its likelihood. Mutations in mtDNA occurring via an increase in reactive oxygen species may favour the occurrence of further changes both in mitochondrial and nuclear DNA. Mitochondrial DNA mutations in postmitotic cells are not inherited, but may play a role both in initiation and progression of cancer. One of the first discovered polymorphisms associated with cancer was in the gene NADH-ubiquinone oxidoreductase chain 3 (mt-ND3) and it was typical of haplogroup N. In prostate cancer, these mutations and polymorphisms involve a gene encoding subunit I of respiratory complex IV cytochrome c oxidase subunit 1 gene (COI). At present, a growing number of studies also address the impact of mtDNA polymorphisms on prognosis in cancer patients. Some of the mitochondrial DNA polymorphisms occur in both chronic disease and cancer, for instance polymorphism G5913A characteristic of prostate cancer and hypertension.